Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities.
(a)
Market Information
Our
units began to trade on The Nasdaq Stock Market LLC, or Nasdaq, under the symbol “MMTXU” on October 23, 2025. Our ordinary
shares and warrants comprising the units began separate trading on Nasdaq on December 15, 2025, under the symbols “MMTX”
and “MMTXW”, respectively.
(b)
Holders
As of December 31, 2025, there were seven holders of record of our ordinary shares, one holder of record of our public warrants, one holder of record of
our private warrants and two holders of record of our units. The number of record holders was determined from the records of our transfer
agent and does not include beneficial owners of ordinary shares and public warrants whose shares are held in the names of various security
brokers, dealers, and registered clearing agencies.
12
(c)
Dividends
We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of a
business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to a business
combination will be within the discretion of our then board of directors. It is the present intention of our board of directors to retain
all earnings, if any, for use in our business operations and, accordingly, our board of directors does not anticipate declaring any dividends
in the foreseeable future.
d)
Securities Authorized for Issuance Under Equity Compensation Plans
None.
e)
Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
On
July 18, 2025, our Sponsor purchased an aggregate of 1,725,000 insider shares for an aggregate of $25,000 (or approximately $0.014
per share), up to 225,000 of which shall be surrendered to us for no consideration after the closing of the IPO on the extent to
which the underwriters’ over-allotment option is exercised. On the same date, 2025, our Sponsor transferred an aggregate of
80,000 insider shares to our then chief executive officer, Mr. Shang Ju Lin, our chief financial officer and our three independent
directors. As a result of the underwriters’ exercise of the over-allotment option on October 25, 2025, none of the insider
shares are subject to surrender or forfeiture.
On
October 24, 2025, we consummated the IPO of 6,000,000 Units, at $10.00 per Unit. Each Unit consists of one ordinary share, and one redeemable
warrant. Each warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment. Later
on October 25, 2025, the underwriters fully exercised their over-allotment option to purchase 900,000 additional Units for an aggregate
of 6,900,000 Units sold.
Simultaneously
with the consummation of the IPO, the over-allotment option and the sale of the Units, the Company consummated the private placement
of 203,100 private units, each private unit consisting of one ordinary share and one redeemable warrant, to the Sponsor at a price of
$10.00 per private unit, generating total gross proceeds of $2,031,000.
For
a description of the use of the proceeds generated in our IPO, see Item 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations of this Annual Report on Form 10-K.
f)
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item
6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.